Effectiveness of Baricitinib in Refractory Seronegative Rheumatoid Arthritis and Uveitis: A Case Report

Baricitinib is a Janus kinase (JAK) inhibitor used to treat refractory rheumatoid arthritis and blocks the subtypes JAK1 and JAK2. A 35-year-old man with seronegative rheumatoid arthritis complicated by bilateral severe non-granulomatous panuveitis was resistant to steroid treatment, multiple conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Yutaka, Murakami, Takanori, Nishitsuka, Koichi, Takakubo, Yuya, Takagi, Michiaki, Yamashita, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795080/
https://www.ncbi.nlm.nih.gov/pubmed/35096866
http://dx.doi.org/10.3389/fmed.2021.764067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795080/
https://www.ncbi.nlm.nih.gov/pubmed/35096866
http://dx.doi.org/10.3389/fmed.2021.764067

Ejemplares similares